Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2018-08-07

Product name:

LIDOCAINE 2% WITH EPINEPHRINE INJECTION

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02479915

Product Monograph/Veterinary Labelling:

Date: 2018-08-07 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

ALBERTA VETERINARY LABORATORIES LTD
7226 107 Ave Se
Calgary
Alberta
Canada T2C 5N6

Class:

Veterinary

Species:

Cattle ,  Horses ,  Cats ,  Sheep ,  Dogs

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular ,  Epidural ,  Block/Infiltration ,  Subcutaneous

Number of active ingredient(s):

2

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote5

0201284005

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
EPINEPHRINE 0.01 MG / ML
LIDOCAINE HYDROCHLORIDE 20 MG / ML
Version 4.0.3

"Page details"

Date modified: